[go: up one dir, main page]

PE22995A1 - Composicion de tiotepa liofilizada estable - Google Patents

Composicion de tiotepa liofilizada estable

Info

Publication number
PE22995A1
PE22995A1 PE1994254198A PE25419894A PE22995A1 PE 22995 A1 PE22995 A1 PE 22995A1 PE 1994254198 A PE1994254198 A PE 1994254198A PE 25419894 A PE25419894 A PE 25419894A PE 22995 A1 PE22995 A1 PE 22995A1
Authority
PE
Peru
Prior art keywords
tiotepa
solution
stable lyophilized
composition
aqueous
Prior art date
Application number
PE1994254198A
Other languages
English (en)
Inventor
Hoffman Joe
S Ku Mannching
Zamora Lourdes
Velez Jorge
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PE22995A1 publication Critical patent/PE22995A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION LIOFILIZADA ESTABLE DEL AGENTE ALQUILANTE ANTITUMORAL TIOTEPA Y UN METODO DE PREPARACION QUE COMPRENDE: 1) PREPARAR UNA SOLUCION ACUOSA DE TIOTEPA; 2) AGREGAR UNA BASE SELECCIONADA ENTRE BICARBONATO DE SODIO Y CARBONATO DE SODIO QUE ELEVE EL pH DE LA SOLUCION A UN NIVEL DE pH DE 7 A 9, FACILITANDO EL CONTACTO INTIMO DE LA BASE CON CRISTALES DE TIOTEPA; 3) SECAR POR CONGELACION LA SOLUCION ACUOSA, ORIGINANDO UN PRODUCTO CON UNA MAYOR ESTABILIDAD Y UNA REDUCIDA FORMACION DE TURBIDEZ CUANDO SE RECONSTITUYE EN UN MEDIO ACUOSO
PE1994254198A 1993-11-09 1994-11-07 Composicion de tiotepa liofilizada estable PE22995A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15050193A 1993-11-09 1993-11-09

Publications (1)

Publication Number Publication Date
PE22995A1 true PE22995A1 (es) 1995-09-08

Family

ID=22534834

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994254198A PE22995A1 (es) 1993-11-09 1994-11-07 Composicion de tiotepa liofilizada estable

Country Status (29)

Country Link
US (1) US5561121A (es)
EP (1) EP0656211B1 (es)
JP (1) JP3726255B2 (es)
KR (1) KR100348382B1 (es)
CN (1) CN1111130A (es)
AR (1) AR023045A2 (es)
AT (1) ATE180670T1 (es)
AU (1) AU690143B2 (es)
CA (1) CA2135265A1 (es)
CZ (1) CZ287052B6 (es)
DE (1) DE69418832T2 (es)
DK (1) DK0656211T3 (es)
ES (1) ES2133152T3 (es)
FI (1) FI116036B (es)
GR (1) GR3031122T3 (es)
HK (1) HK1011283A1 (es)
HU (1) HU218216B (es)
IL (1) IL111534A (es)
NO (1) NO305274B1 (es)
NZ (1) NZ264861A (es)
PE (1) PE22995A1 (es)
PH (1) PH31219A (es)
PL (1) PL176984B1 (es)
RU (1) RU2134112C1 (es)
SG (1) SG63584A1 (es)
SI (1) SI0656211T1 (es)
SK (1) SK280840B6 (es)
TW (1) TW344662B (es)
ZA (1) ZA948833B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726343D0 (en) * 1997-12-13 1998-02-11 Auffret Anthony The use of excipients to accelerate freeze-drying
AU2002302814A1 (en) * 2001-06-08 2002-12-23 Powderject Vaccines, Inc. Spray freeze-dried compositions
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
BRPI1004922A2 (pt) 2009-01-15 2019-09-24 Cephalon Inc composição farmacêutica, forma cristalina da base livre de bendamustina e método de tratamento de leucemia linfocítica crônica, doença de hodgkin, linfoma não-hodgkin, mieloma múltiplo ou câncer da mama
EP2760851A1 (en) * 2011-09-29 2014-08-06 Janssen Pharmaceutica, N.V. Process for the preparation of sulfamide derivatives
CN104349417B (zh) * 2013-08-07 2017-11-21 中国科学院声学研究所 基于短生命周期的区域性水下通信网的组网方法
WO2018227112A1 (en) * 2017-06-09 2018-12-13 The Trustees Of Columbia University In The City Of New York Short tat oligomers for drug delivery
CN109956972A (zh) * 2017-12-22 2019-07-02 四川科瑞德凯华制药有限公司 塞替派晶型i及其制备方法和用途
CN110917146A (zh) * 2019-12-03 2020-03-27 黑龙江福和制药集团股份有限公司 一种塞替派粉针及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2670347A (en) * 1952-01-08 1954-02-23 American Cyanamid Co Thiophosphoric acid derivatives and method of preparing the same
GB845823A (en) * 1957-09-19 1960-08-24 Sumitomo Chemical Co Stabilised compositions comprising therapeutic imine derivatives and the preparation thereof
DE1951822C3 (de) * 1969-10-14 1980-12-11 Kowa Co., Ltd., Nagoya, Aichi (Japan) Pharmazeutisches Präparat zur Krebsbehandlung
DE2925009A1 (de) * 1979-06-21 1981-01-08 Basf Ag Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
WO1984001506A1 (en) * 1982-10-13 1984-04-26 Univ Birmingham Pharmaceutical preparations for use in antitumour therapy
EP0140255B1 (en) * 1983-10-14 1991-05-15 Sumitomo Pharmaceuticals Company, Limited Sustained-release injections
CH676508A5 (es) * 1986-10-13 1991-01-31 Anawa Lab Ag
US4918199A (en) * 1988-01-21 1990-04-17 American Cyanamid Company Process for producing thiotepa
US5122367A (en) * 1989-03-31 1992-06-16 Massachusetts Institute Of Technology Polyanhydride bioerodible controlled release implants for administration of stabilized growth hormone
EP0419890A3 (en) * 1989-09-29 1991-05-29 American Cyanamid Company Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method

Also Published As

Publication number Publication date
NZ264861A (en) 1995-10-26
SI0656211T1 (en) 1999-08-31
IL111534A (en) 1999-06-20
DE69418832T2 (de) 1999-09-23
SK280840B6 (sk) 2000-08-14
AR023045A2 (es) 2002-09-04
AU7768994A (en) 1995-05-18
KR100348382B1 (ko) 2002-11-23
HU218216B (hu) 2000-06-28
EP0656211B1 (en) 1999-06-02
ATE180670T1 (de) 1999-06-15
DE69418832D1 (de) 1999-07-08
FI945252L (fi) 1995-05-10
NO305274B1 (no) 1999-05-03
DK0656211T3 (da) 1999-11-15
AU690143B2 (en) 1998-04-23
ZA948833B (en) 1995-07-14
PL305752A1 (en) 1995-05-15
PH31219A (en) 1998-05-05
US5561121A (en) 1996-10-01
TW344662B (en) 1998-11-11
CN1111130A (zh) 1995-11-08
NO944256D0 (no) 1994-11-08
HU9403210D0 (en) 1995-01-30
FI945252A0 (fi) 1994-11-08
IL111534A0 (en) 1995-01-24
EP0656211A1 (en) 1995-06-07
RU94040150A (ru) 1996-09-20
JPH07196517A (ja) 1995-08-01
SK135294A3 (en) 1996-01-10
SG63584A1 (en) 1999-03-30
GR3031122T3 (en) 1999-12-31
CZ271894A3 (en) 1995-07-12
CZ287052B6 (en) 2000-08-16
HK1011283A1 (en) 1999-07-09
CA2135265A1 (en) 1995-05-10
ES2133152T3 (es) 1999-09-01
RU2134112C1 (ru) 1999-08-10
HUT70762A (en) 1995-10-30
PL176984B1 (pl) 1999-08-31
JP3726255B2 (ja) 2005-12-14
FI116036B (fi) 2005-09-15
NO944256L (no) 1995-05-10

Similar Documents

Publication Publication Date Title
PE22995A1 (es) Composicion de tiotepa liofilizada estable
PL319603A1 (en) Stable aqueous alpha interferon preparations
ES2052016T3 (es) Composicion emulsionada.
IE881288L (en) Stabilized hydrogen peroxide solutions
WO2001016267A8 (en) Foaming effervescent bath product
ES2033977T3 (es) Un procedimiento para preparar una composion antiacida.
ES2084656T3 (es) Composicion liquida acida espesada con abrillantadores opticos sulfonados.
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ATE47715T1 (de) Stabile salze von sam mit polyanionen.
SG50568A1 (en) High salt content rapid disinfection solution for contact lenses
ES2007068A6 (es) Procedimiento para el blanqueo de material fibroso celulosico.
BR9913479A (pt) Solubilização de baixos sulfonatos de 2-fenil alquilbenzeno
KR940011001A (ko) 인공 타액(唾液)
MX169821B (es) Compociciones limpiadoras cremosas
ES2067052T3 (es) Procedimiento para el tratamiento final de tensioactivos anfoteros o zwitterionicos.
DE3480258D1 (en) Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts
ES2071642T3 (es) Composiciones detergentes liquidas.
DK1018345T3 (da) Vandoplöselige, törre sammensætninger
ES2000033A6 (es) Composicion de bitionol sulfoxido porcedimiento para su fabricacion y metodo de utilizacion de aquella
DE3485221D1 (de) In waessrigen medien dispergierbare granulierte zusammensetzung von in wasser schwer- oder unloeslichen wirkstoffen.
ES2087863T3 (es) Composicion limpiacristales.
AU2002215169A1 (en) Sanitizing composition containing chlorinated isocyanurate for in-ovo injection equipment
ES8802560A1 (es) Un metodo para la preparacion de derivados estables efervescentes de acido acetilsalicilico con propiedades antihistaminicas.
DE3673099D1 (de) Alkalivertraegliche amphoterische sulfobetain-tenside.
ES2085892T3 (es) Composicion suavizante de tejidos.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed